P666: Trend of Lower gastrointestinal Endoscopy in Patients with Inflammatory Bowel Diseases : A Nationwide Population-Based Study in South KoreaECCO'22Year: 2022
Authors: Kim, S.(1);Lee, S.(2);Han, K.(2);Soh, H.(1);Koh, S.J.(3);Lee, H.J.(1);Im, J.P.(1);Kim, J.S.(1);
(1)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;(2)Soongsil University, Department of Statistics and Actuarial Science, Seoul, Korea- Republic Of;(3)Seoul National University College of Medicine- Seoul, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;
P667: Unmet needs in the management of Inflammatory Bowel Diseases in EgyptECCO'22Year: 2022
Authors: KhorshidFASGE, M.(1);Abdel-Gawad, M.(2);AbdAllah, M.(3);Tag-Adeen, M.(4);Afify, S.(5);El Deeb, R.(6);Elshaarawy, O.(7);Elbasiony, M.(8);Bassuny, A.N.(9);El-Raey, F.(10);Fathy, H.(11);ElShabacy, O.(12);Cordie, A.(13);Abdelmoaty, A.(14);Elbahr, O.(7);Ali-Eldin, Z.(15);Alboraie, M.(16);
(1)EDGE Foundation, Department of Clinical Research, Cairo, Egypt;(2)Al-Azhar University Assiut Branch, Hepatology- Gastroenterology and Infectious Diseases, Assiut, Egypt;(3)National Research Center, Medical Research Division, Cairo, Egypt;(4)South Valley University - Qena Faculty of Medicine, Department of Internal Medicine, Qena, Egypt;(5)National Hepatology and Tropical medicine Research Institute, Department of Gastroenterology, Cairo, Egypt;(6)Alexandria University, Tropical medicine department, Alexandria, Egypt;(7)National Liver Institute- Menoufia University, Department of Hepatology- Gastroenterology and Liver Transplantation, Menoufia, Egypt;(8)Mansoura University, Department of internal medicine, Mansoura, Egypt;(9)Ain Shams University, Department of Tropical medicine, Cairo, Egypt;(10)Al-Azhar University Damietta Branch, Department of Hepatogastroenterology and Infectious diseases, Damietta, Egypt;(11)Assiut university, Hepatogasteroenterology unit, Assiut, Egypt;(12)National Research Center, Department of complementary medicine- medical division, Cairo, Egypt;(13)Cairo University, Department of Endemic medicine and hepatology, Cairo, Egypt;(14)Zagazig University, Department tropical medicine, Zagazig, Egypt;(15)Ain shams University, Department of internal medicine, Cairo, Egypt;(16)Al-Azhar University, Department of internal medicine, Cairo, Egypt;
P668: Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Orfanoudaki, E.(1);Zacharopoulou, E.(2);Kitsou, V.(3);Karmiris, K.(4);Theodoropoulou, A.(4);Mantzaris , G.J.(5);Tzouvala, M.(2);Michopoulos , S.(6);Zampeli, E.(6);Michalopoulos, G.(7);Karatzas, P.(8);Viazis, N.(5);Liatsos, C.(9);Bamias, G.(10);Koutroubakis, I.E.(1);
(1)University Hospital of Heraklion- Medical School- University of Crete, Department of Gastroenterology, Heraklion Crete, Greece;(2)General Hospital of Nikaia Piraeus @Ag. Panteleimon@-General Hospital Dytikis Attikis @Agia Varvara@, Department of Gastroenterology, Athens, Greece;(3)3rd Academic Department of Internal Medicine- National and Kapodistrian Univeristy of Athens- @Sotiria@ General Hospital, Gastroenterology Unit, Athens, Greece;(4)Venizelio General Hospital, Department of Gastroenterology, Heraklion Crete, Greece;(5)General Hospital of Athens- Evaggelismos- Polykliniki, Department of Gastroenterology, Athens, Greece;(6)General Hospital of Athens @Alexandra@, Department of Gastroenterology, Athens, Greece;(7)General Hospital of Piraeus @Tzaneio, Department of Gastroenterology, Piraeus Athens, Greece;(8)National and Kapodistrian University of Athens- General Hospital of Athens @Laiko@, Department of Gastroenterology, Athens, Greece;(9)401 General Army Hospital of Athens, Department of Gastroenterology, Athens, Greece;(10)3rd Academic Department of Internal Medicine- National and Kapodistrian Univeristy of Athens- @Sotiria@ General Hospital, Gastroenterology Unit, Athens, Greece;Hellenic group for the study of IBD
P669: Validation of prior infliximab exposure and total colectomy outcome in patients with ulcerative colitis in SwedenECCO'22Year: 2022
Authors: Huang, Z.(1);Hill, D.(1);Bengtsson, C.(2);Wang, M.(2);Hakkarainen, K.M.(3);Hellström, P.M.(4);
(1)Merck & Co. Inc., Epidemiology, Kenilworth, United States;(2)IQVIA, Global Database Studies- Real-World Solutions, Solna, Sweden;(3)IQVIA, Global Database Studies- Real-World Solutions, Gothenburg, Sweden;(4)Uppsala University, Department of Medical Sciences- Gastroenterology unit, Uppsala, Sweden;
P670: Familial Inflammatory Bowel Disease is associated with a more adverse disease compared to sporadic casesECCO'22Year: 2022
Authors: Boaz, E.(1);Ariella, B.G.S.(2);Menachem, S.(2);Eran, G.(2);Petachia, R.(1);Shlomo, Y.(1);Koslowsky, B.(2);
(1)Shaare Zedek Medical Center, Department of Surgery, Jerusalem, Israel;(2)Shaare Zedek Medical Center, Department of Gastroenterology, Jerusalem, Israel;
P671: Occurrence and clinical impact of eosinophilic esophagitis in a large cohort of children with Inflammatory Bowel Disease.ECCO'22Year: 2022
Authors: Aloi, M.(1);Rossetti, D.(1);Bucherini, S.(1);Felici, E.(2);Romano, C.(3);Martinelli, M.(4);Di Pasquale, V.(5);Lionetti, P.(6);Oliva, S.(7);
(1)Sapienza University of Rome, Pediatric Gastroenterology and Liver Unit, Rome, Italy;(2)Cesare Arrigo Hospital, Department of Pediatrics, Alessandria, Italy;(3)University of Messina, Pediatric Gastroenterology and Endoscopy Unit, Messina, Italy;(4)Federico II University, Gastroenterology Unit, Naples, Italy;(5)University of Messina, Gastroenterology and Endoscopy Unit, Messina, Italy;(6)Meyer Hospital, Gastroenterology Unit, Florence, Italy;(7)Sapienza University of Rome, Gastroenterology and Liver Unit, Rome, Italy;SIGENP IBD Working Group
P672: Biologic therapy for Inflammatory Bowel Disease in Poland in 2020: nationwide data.ECCO'22Year: 2022
Authors: Kucha, P.(1);Zagórowicz, E.(1,2);Walkiewicz, D.(3);Perwieniec, J.(3);Maluchnik, M.(3,4);Wieszczy, P.(2);Reguła, J.(1,2);
(1)Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Department of Oncological Gastroenterology, Warsaw, Poland;(2)Centre of Postgraduate Medical Education, Department of Gastroenterology, Warsaw, Poland;(3)Ministry of Health in Poland, Department of Analyses and Strategies, Warsaw, Poland;(4)Medical University of Gdansk, Department of Adult Neurology, Gdańsk, Poland;
P674: Predictors of response to biologics in Crohn's Diseases: A population-based study from the epi-IIRNECCO'22Year: 2022
Authors: Atia, O.(1); Lujan, R.(1); Greenfeld, S.(2); Kariv, R.(3); Matz, E.(4);Dotan, I.(5); Nevo, D.(6); Turner, D.(1);
(1)Shaare Zedek Medical Center- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Maccabi Health Services, Maccabi Health Services and the Sackler Faculty of Medicine, Tel-Aviv, Israel;(3)Maccabi Health Services, Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Tel-Aviv, Israel;(4)Leumit Health Services, Leumit Health Services, Tel-Aviv, Israel;(5)Rabin Medical Center and the Sackler Faculty of Medicine- Tel Aviv University, Division of Gastroenterology, Petah Tikva, Israel;(6)Tel Aviv University- Israel, Department of Statistics and Operations Research, Tel-Aviv, Israel;
P675: Associations between Inflammatory Bowel Disease, social isolation, and mortality: evidence from UK Biobank cohort studyECCO'22Year: 2022
Authors: Chen, J.(1);Geng, J.(1);Wang, J.(2);Fu, T.(2);Sun, Y.(1);Chen, H.(3);Chen, X.(2);Wang, X.(2);Hesketh, T.(1);
(1)Zhejiang University, Center for Global Health, Hangzhou, China;(2)The Third Xiangya Hospital of Central South University, Department of Gastroenterology, Changsha, China;(3)School of Public Health, Zhejiang University, Hangzhou, China;
P676: Burden of depression and anxiety among inflammatory bowel disease patients in a national cohort in Israel – Data from the EPI-IIRNECCO'22Year: 2022
Authors: Mekori - Domachevsky, E..(1);Ziv - Baran, T.(2);Loewenberg Weisband, Y.(3);Greenfeld, S.(4);Kariv, R.(4);Erez, M.(5);Friss, F.(6);Focht, G.(6);Turner, D.(6);Ben - Horin, S.(1);Kopylov, U.(1);
(1)Sheba Medical Center, Gastroenterology Department, Ramat Gan, Israel;(2)Tel Aviv University, Department of Epidemiology and Preventive Medicine- School of Public Health- Sackler Faculty of Medicine, Tel Aviv, Israel;(3)Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel;(4)Maccabi Health Services, Medical Informatics Department, Tel Aviv, Israel;(5)Leumit Medical Services, Leumit Medical Services, Tel Aviv, Israel;(6)Shaare Zedek Medical Center, Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;IIRN
P677: Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registryECCO'22Year: 2022
Authors: Zacharopoulou, E.(1);Orfanoudaki, E.(2);Kitsou, V.(3);Tzouvala, M.(1);Tribonias, G.(1);Mantzaris, G.J.(4);Viazis, N.(4);Christidou, A.(4);Almpani, F.(4);Karmiris, K.(5);Theodoropoulou, A.(5);Tsafaridou, M.(2);Michopoulos, S.(6);Zampeli, E.(6);Papathanasiou, E.(6);Michalopoulos, G.(7);Tigkas, S.(7);Karatzas, P.(8);Laoudi, E.(8);Liatsos, C.(9);Kyriakos, N.(9);Mylonas, I.(9);Theocharis, G.(10);Koutroubakis, I.E.(2);Bamias, G.(3);
(1)General Hospital of Nikaia Piraeus @Agios Panteleimon@- General Hospital Dytikis Attikis @Agia Varvara@, Department of Gastroenterology, Athens, Greece;(2)University Hospital of Heraklion- Medical School- University of Crete, Department of Gastroenterology, Heraklion Crete, Greece;(3)National and Kapodistrian Univeristy of Athens- @Sotiria@ General Hospital, 3rd Academic Department of Internal Medicine, Athens, Greece;(4)General Hospital of Athens- Evaggelismos- Polykliniki, Department of Gastroenterology-, Athens, Greece;(5)Venizelio General Hospital, Department of Gastroenterology, Heraklion Crete, Greece;(6)General Hospital of Athens @Alexandra@, Department of Gastroenterology-, Athens, Greece;(7)General Hospital of Piraeus @Tzaneio@, Department of Gastroenterology, Piraeus, Greece;(8)National and Kapodistrian University of Athens- General Hospital of Athens @Laiko@, Department of Gastroenterology, Athens, Greece;(9)401 General Army Hospital of Athens-, Department of Gastroenterology, Athens, Greece;(10)University Hospital of Patras, Department of Gastroenterology, Patra, Greece;
P678: Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety RegistryECCO'22Year: 2022
Authors: Klomberg, R.(1);Kemos, P.(2);Chondrou, P.(2);Croft, N.(2);de Ridder, L.(1);
(1)Erasmus MC - Sophia Children's Hospital, Paediatric Gastroenterology, Rotterdam, The Netherlands;(2)Center for Immunobiology- Blizard Institute- Barts and the London School of Medicine- Queen Mary University of London, Paediatric gastroenterology, London, United Kingdom;
P679: Inflammatory Bowel Disease and cancer risk in the IBSEN study after 30 years of follow-up.ECCO'22Year: 2022
Authors: Follin-Arbelet, B.(1);Småstuen Cvancarova, M.(2);Hovde, Ø.(3);Jelsness-Jørgensen, L.P.(4);Moum, B.(2);
(1)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(2)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(3)Innlandet Hospital Trust, Medical Department, Gjøvik, Norway;(4)Østfold University College, Østfold University College, Fredrikstad, Norway;
P680: Epidemiology of Inflammatory Bowel Disease in Poland 2009-2020: nationwide dataECCO'22Year: 2022
Authors: Zagórowicz, E.S.(1);Walkiewicz, D.(2);Kucha, P.(1);Perwieniec, J.(2);Maluchnik, M.(2,3);Wieszczy, P.(4);Reguła, J.(4);
(1)Maria Sklodowska-Curie Memorial Cancer Center Institute of Oncology, Department of Oncological Gastroenterology Warsaw, Warsaw, Poland;(2)Ministry of Health in Poland, Department of Analyses and Strategies, Warsaw, Poland;(3)Medical University of Gdansk, Adult Neurology, Gdańsk, Poland;(4)Centre of Postgraduate Medical Education, Department of Gastroenterology, Warsaw, Poland;
P681: Impact of Crohn’s disease on survival in Korean patients with small bowel adenocarcinomaECCO'22Year: 2022
Authors: Kim, K.(1);Choi, K.(2);Hwang, S.W.(1);Im, J.P.(2);Ye, B.D.(1);Kim, J.S.(2);Yang, S.K.(1);Koh, S.J.(2);Park, S.H.(1);
(1)University of Ulsan College of Medicine- Asan Medical Center, Department of gastroenterology, Seoul, Korea- Republic Of;(2)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;
P682: Predictors of response to biologics in Ulcerative Colitis: A population-based study from the epi-IIRNECCO'22Year: 2022
Authors: Atia, O.(1); Lujan, R.(1); Greenfeld, S.(2); Kariv, R.(2); Matz, E.(3); Dotan, I.(4); Nevo, D.(5);Turner, D.(1);
(1)Shaare Zedek Medical Center- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University- Israel., Maccabi Health Services, Tel-Aviv, Israel;(3)Leumit Health Services, Leumit Health Services, Tel-Aviv, Israel;(4)Rabin Medical Center and the Sackler Faculty of Medicine- Tel Aviv University- Israel., Division of Gastroenterology, Petah Tikva, Israel;(5)Tel Aviv University- Israel, Department of Statistics and Operations Research- Tel Aviv University- Israel, Tel Aviv, Israel;
P683: Discontinuation of infliximab treatment: a comparison between IBD patients who retransitioned to originator and those who remained on biosimilarECCO'22Year: 2022
Authors: Meijboom, R.(1);Gardarsdottir, H.(2);Becker, M.(1);Movig, K.(3);Egberts, T.(2);Giezen, T.(1);
(1)Pharmacy Foundation of Haarlem Hospitals- Haarlem- the Netherlands, Pharmacy Foundation of Haarlem Hospitals- Haarlem- the Netherlands, Haarlem, The Netherlands;(2)Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht, The Netherlands;(3)Medisch Spectrum Twente, Department of Clinical Pharmacy, Enschede, The Netherlands;
P684: Increased risk of cardiovascular disease and high risk profiles compatible with metabolic syndrome in patients with Inflammatory Bowel Disease: a cross-sectional analysis of matched cohortsECCO'22Year: 2022
Authors: SleutjesAM, J.(1);Roeters van Lennep, J.E.(2);Kavousi, M.(3);Aribas, E.(3);van der Woude, C.J.(4);de Vries, A.C.(4);
(1)Erasmus Medical Centre, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(2)Erasmus Medical Center, Internal Medicine, Rotterdam, The Netherlands;(3)Erasmus Medical Center, Epidemiology of Cardiometabolic Disorders, Rotterdam, The Netherlands;(4)Erasmus Medical Center, Gastroenterology & Hepatology, Rotterdam, The Netherlands;
P685: Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel DiseasesECCO'22Year: 2022
Authors: Kappelman, M.(1);Weaver, K.(2);Zhang, X.(1);Chun, K.(3);Long, M.(2);
(1)University of North Carolina, Division of Pediatric Gastroenterology- Department of Pediatrics, Chapel Hill, United States;(2)University of North Carolina, Medicine, Chapel Hill, United States;(3)Labcorp, Esoterix, Calabasas, United States;PREVENT-COVID Study Group
